Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Howard University is currently navigating 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are being reviewed by 4 distinct examiners, which means the number of pending cases matches the number of individuals assigned to evaluate them. This distribution suggests that no single examiner is currently overwhelmed by the university's specific portfolio.
The prosecution activity is concentrated within 2 distinct art units. This concentration indicates that while the technology area is broad, the specific inventions are categorized into a limited number of specialized groups at the patent office. HAGOPIAN, CASEY SHEA is the busiest examiner for this portfolio, currently managing 1 pending office action.
Because the busiest examiner is only responsible for 1 pending office action, the workload is perfectly balanced across the examiners. Practitioners can expect individualized attention from each examiner, as the pending office actions are not clustered under a single point of contact. This lack of examiner overlap across the 2 distinct art units may lead to varied prosecution experiences depending on the specific group assigned.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Double-patenting only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGOPIAN, CASEY SHEA | 1 | 54.4% | +33.3% |
| AZPURU, CARLOS A | 1 | 83.8% | +10.7% |
| BRADLEY, CHRISTINA | 1 | 62.6% | +33.3% |
| BARRERA, IMMACULADA | 1 | 31.0% | +80.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18824295 | NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS | AZPURU, CARLOS A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925474 | COMPOSITIONS AND METHODS FOR TREATING AND DETECTING CORONAVIRUS INFECTION | BARRERA, IMMACULADA | 26d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17925474 | COMPOSITIONS AND METHODS FOR TREATING AND DETECTING CORONAVIRUS INFECTION | BARRERA, IMMACULADA | 26d overdue |
| 18173264 | VIRAL RECEPTOR-DERIVED PEPTIDES AGAINST VIRAL DISEASES | BRADLEY, CHRISTINA | 75d |
| 18959847 | POLYSACCHARIDE-POLYAMINE COPOLYMERS FOR REMOVAL OF PHOSPHATE | HAGOPIAN, CASEY SHEA | — |
| 18824295 | NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS | AZPURU, CARLOS A | — |
| Art Unit | Apps |
|---|---|
| 1654 | 1 |
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18959847 | POLYSACCHARIDE-POLYAMINE COPOLYMERS FOR REMOVAL OF PHOSPHATE | HAGOPIAN, CASEY SHEA | — | §103DP | Non-Final OA | — | Pending | Nov 26, 2024 |
| 18824295 | NUCLEIC ACID NANOSHELLS FOR CO-DELIVERING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS AND METHODS OF MANUFACTURING NUCLEIC ACID NANOSHELLS CONTAINING PROTEINS AND PROTEIN-CONTAINING COMPOUNDS | AZPURU, CARLOS A | — | DP | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18173264 | VIRAL RECEPTOR-DERIVED PEPTIDES AGAINST VIRAL DISEASES | BRADLEY, CHRISTINA | 1654 | §103 | Final Rejection | 75d | Pending | Feb 23, 2023 |
| 17925474 | COMPOSITIONS AND METHODS FOR TREATING AND DETECTING CORONAVIRUS INFECTION | BARRERA, IMMACULADA | 1671 | §101§103§112 | Final Rejection | 26d overdue | Pending | Nov 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial